MAXCYTE INC. - COMMON
3.8800
08-October-24 15:59:58
15 minutes delayed
Stocks
+0.1000
+2.65%
Today's range
3.7500 - 3.8900
ISIN
N/A
Source
NASDAQ
-
MaxCyte to Participate in Two Upcoming Investor Conferences
06 Nov 2023 16:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance
04 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing
06 Sep 2023 08:05:00 By Nasdaq GlobeNewswire
-
MaxCyte to Participate in Baird Global Healthcare Conference
05 Sep 2023 08:05:00 By Nasdaq GlobeNewswire
-
09 Aug 2023 16:05:01 By Nasdaq GlobeNewswire
-
01 Aug 2023 08:05:51 By Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023
13 Jul 2023 08:05:00 By Nasdaq GlobeNewswire
-
10 Jul 2023 08:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Signs Strategic Platform License with Lyell Immunopharma
06 Jul 2023 08:05:05 By Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
01 Jun 2023 16:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Guidance
10 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
04 May 2023 08:05:53 By Nasdaq GlobeNewswire
-
MaxCyte to Report First Quarter 2023 Financial Results on May 10, 2023
12 Apr 2023 16:05:30 By Nasdaq GlobeNewswire
-
MaxCyte Appoints Douglas Swirsky as Chief Financial Officer
27 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Reports Fourth Quarter and Full Year 2022 Financial Results
15 Mar 2023 16:05:23 By Nasdaq GlobeNewswire
-
08 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
06 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
01 Feb 2023 16:05:53 By Nasdaq GlobeNewswire
-
03 Jan 2023 16:05:00 By Nasdaq GlobeNewswire
-
05 Dec 2022 02:00:00 By Nasdaq GlobeNewswire